Jeffrey MING,Moshe E. ZILBERSTEIN,Roghieh KARIMI ANDERESI
申请号：
US15927675
公开号：
US20180280500A1
申请日:
2018.03.21
申请国别(地区):
US
年份:
2018
代理人:
摘要：
This disclosure provides anti-CXCR5 antibodies and their use in the amelioration, treatment, or prevention of lupus. The disclosure also provides prophylactic, immunotherapeutic, and diagnostic compositions comprising an anti-CXCR5 antibody, and the use of such anti-CXCR5 antibodies in methods of preventing or treating lupus in mammals, including humans.
